Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilate in children under 6 years with inherited von Willebrand disease
2005-001426-84Phase 2Completed
- Sponsor
- Octapharma
- Start
- Oct 2005
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Octapharma. Primary endpoints: Efficacy in prevention and treatment of bleeding episodes and Efficacy in surgical procedures. Started Oct 2005; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on 2005-001426-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001426-84.